KeyBanc Sticks to Their Buy Rating for Athenahealth

By Austin Angelo

In a report released today, Brent Bracelin from KeyBanc reiterated a Buy rating on Athenahealth (NASDAQ: ATHN), with a price target of $170. The company’s shares closed on Friday at $128.94.

According to, Bracelin is a 5-star analyst with an average return of 12.0% and a 72.8% success rate. Bracelin covers the Technology sector, focusing on stocks such as Cornerstone Ondemand, Riverbed Technology, and Medidata Solutions.

Athenahealth has an analyst consensus of Moderate Buy, with a price target consensus of $155.92.

Athenahealth’s market cap is currently $5.14B and has a P/E ratio of 162.27. The company has a book value ratio of 7.1753.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

athenahealth, Inc. provides cloud-based business services and mobile applications for medical groups and health systems. It also provides ongoing billing, clinical-related, and other related services to customers. The company offers practice management and electronic health record services.